Document Detail


Oral intake of rosiglitazone promotes a central antihypertensive effect via upregulation of peroxisome proliferator-activated receptor-gamma and alleviation of oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats.
MedLine Citation:
PMID:  20404217     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Rosiglitazone, a synthetic ligand of transcription factor peroxisome proliferator-activated receptor-gamma (PPAR-gamma), possesses a blood pressure-lowering effect beyond insulin sensitizing and glucose lowering. Oxidative stress in rostral ventrolateral medulla (RVLM), where sympathetic premotor neurons for the maintenance of neurogenic vasomotor tone are located, contributes to neural mechanisms of hypertension. Activation of PPAR-gamma protects against oxidative stress in RVLM by upregulation of mitochondrial uncoupling protein 2 (UCP2). We tested the hypothesis that oral intake of rosiglitazone exerts a central antihypertensive effect by ameliorating oxidative stress in RVLM via transcriptional upregulation of UCP2 after PPAR-gamma activation. In adult spontaneously hypertensive rats but not normotensive Wistar-Kyoto rats, oral intake of rosiglitazone for 1 week resulted in vasodepression and a reduction in the vasomotor components of the systemic arterial pressure spectrum, our experimental index for sympathetic vasomotor tone. These antihypertensive effects of rosiglitazone in spontaneously hypertensive rats were abrogated by microinjection bilaterally into RVLM of PPAR-gamma small interfering RNA. Oral intake of rosiglitazone also upregulated UCP2 and ameliorated the heightened superoxide anion level in RVLM of spontaneously hypertensive rats. Protection against oxidative stress in RVLM by rosiglitazone was abrogated by PPAR-gamma small interfering RNA or by antisense oligonucleotide against ucp2 mRNA. Gene knockdown of ucp2 in RVLM also reversed the antihypertensive effect of rosiglitazone. These results suggest that oral intake of rosiglitazone promotes a central antihypertensive effect by decreasing sympathetic vasomotor activity through a PPAR-gamma-dependent protection against oxidative stress in RVLM via transcriptional upregulation of the mitochondrial UCP2.
Authors:
Samuel H H Chan; Kay L H Wu; Peter S S Kung; Julie Y H Chan
Related Documents :
22469627 - Biperiden (m(1) antagonist) impairs the expression of cocaine conditioned place prefere...
22326697 - The effects of morphine and morphine conditioned context on 50khz ultrasonic vocalisati...
22398437 - Protective effect of flos carthami extract against ethylene glycol-induced urolithiasis...
11776097 - A preliminary investigation of tanakan in the treatment of hypertensive arteriosclerosi...
16910177 - Behavioral toxicity of increasing doses of ethanol in malnourished rats.
9839667 - Effect of tityus serrulatus scorpion toxin on serum gastrin levels in anaesthetized rat.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-04-19
Journal Detail:
Title:  Hypertension     Volume:  55     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-20     Completed Date:  2010-06-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1444-53     Citation Subset:  IM    
Affiliation:
Center for Translation Research in Biomedical Sciences, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan, Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Amlodipine / pharmacology
Analysis of Variance
Animals
Blood Pressure / drug effects,  physiology
Disease Models, Animal
Heart Rate / drug effects,  physiology
Hypertension / drug therapy,  physiopathology*
Kidney Medulla / drug effects,  physiology
Male
Oxidative Stress / drug effects*,  physiology
PPAR gamma / drug effects*,  genetics*,  metabolism
Probability
RNA, Messenger / metabolism
Random Allocation
Rats
Rats, Inbred SHR
Rats, Inbred WKY
Reverse Transcriptase Polymerase Chain Reaction
Thiazolidinediones / pharmacology*
Up-Regulation
Vasodilator Agents / pharmacology
Chemical
Reg. No./Substance:
0/PPAR gamma; 0/RNA, Messenger; 0/Thiazolidinediones; 0/Vasodilator Agents; 122320-73-4/rosiglitazone; 88150-42-9/Amlodipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  From Blood Pressure to Physical Disability. The Role of Cognition.
Next Document:  Filling Pressures and Collagen Metabolism in Hypertensive Patients With Heart Failure and Normal Eje...